Protocol fidelity and transparency about changes are essential to the credibility of randomised controlled trials In recent ...
The traditional gold standard of clinical trials with a randomized, placebo-controlled design involving hundreds of patients ...
New SOL-1 post-hoc analyses presented at VBS reinforce AXPAXLI’s unmatched durability in wet AMD with sustained disease control. AXPAXLI demonstrated robust CSFT control with a ...
In dementia care relying only on randomized controlled trials can leave out a large amount of strong research that reflects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results